Lamassu Pharma
Greg Palmer is a Biomedical engineer with expertise in imaging, medical devices, and translational science. Academic career as a faculty member focused on translational science and quantitative assessments of tissue structure and function through intravital imaging and spectroscopy. Cofounder of Preclinical Pathfinder a private CRO, and co-inventor and scientist for Zenalux, a start-up dedicated to optical sensing in cancer. Experience in animal models, and focus on improving preclinical reproducibility and predictability. Leading and managing 10’s of preclinical drug and device development projects annually.
This person is not in any offices
Lamassu Pharma
1 followers
Lamassu Pharma leverages innovative and collaborative approaches to drive collaboration between academia and industry through translational research.